Abstract
Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) is responsible for the current coronavirus disease 2019 (COVID-19) pandemic. Signaling pathways that are essential for virus production have potential as therapeutic targets against COVID-19. In this study, we investigated cellular responses in two cell lines, Vero and Calu-3, upon SARS-CoV-2 infection and evaluated the effects of pathway-specific inhibitors on virus production. SARS-CoV-2 infection induced dephosphorylation of STAT1 and STAT3, high virus production, and apoptosis in Vero cells. However, in Calu-3 cells, SARS-CoV-2 infection induced long-lasting phosphor-ylation of STAT1 and STAT3, low virus production, and no prominent apoptosis. Inhibitors that target STAT3 phosphorylation and dimerization reduced SARS-CoV-2 production in Calu-3 cells, but not in Vero cells. These results suggest a necessity to evaluate cellular consequences upon SARS-CoV-2 infection using various model cell lines to find out more appropriate cells recapitulating relevant responses to SARS-CoV-2 infection in vitro.
Author supplied keywords
Cite
CITATION STYLE
Park, B. K., Kim, D., Park, S., Maharjan, S., Kim, J., Choi, J. K., … Kwon, H. J. (2021). Differential signaling and virus production in calu-3 cells and vero cells upon sars-cov-2 infection. Biomolecules and Therapeutics, 29(3), 273–281. https://doi.org/10.4062/biomolther.2020.226
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.